New-onset diabetes confers increased risk for pancreatic cancer in a large cohort of US veterans

被引：0
|
作者：
Gupta, S
Bertenthal, D
Shen, H
Vittinghoff, E
McQuaid, K
机构：
[1] Univ Calif San Francisco, VA Med Ctr, GI Div, San Francisco, CA 94143 USA
[2] VA Med Ctr, Hlth Serv Res Enhancement Award Program, San Francisco, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00732
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
732
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [21] New-Onset Diabetes With a History of Dyslipidemia Predicts Pancreatic Cancer
    Tseng, Chin-Hsiao
    PANCREAS, 2013, 42 (01) : 42 - 48
  • [22] New-Onset Diabetes Mellitus Is Not Associated with the Prognosis of Pancreatic Cancer
    Mizuno, Suguru
    Nakai, Yousuke
    Yamamoto, Keisuke
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Sasaki, Takashi
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Isayama, Hiroyuki
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    GASTROENTEROLOGY, 2009, 136 (05) : A390 - A390
  • [23] Contribution of biomarkers for pancreatic cancer -associated new-onset diabetes to pancreatic cancer screening
    Zhang, Zhenjun
    Qin, Wenjie
    Sun, Yuling
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (12) : 1923 - 1928
  • [24] Pancreatic cyst, not new-onset diabetes, is the clue to early diagnosis of pancreatic cancer
    Nakai, Yousuke
    Tada, Minoru
    Yashima, Yoko
    Yagioka, Hiroshi
    Kogure, Hirofumi
    Sasaki, Takashi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Hirano, Kenji
    Sasahira, Naoki
    Tsujino, Takeshi
    Isayama, Hiroyuki
    Kawabe, Takao
    Omata, Masao
    GASTROENTEROLOGY, 2008, 134 (04) : A696 - A696
  • [25] Exocrine Pancreatic Dysfunction Increases the Risk of New-Onset Diabetes Mellitus: Results of a Nationwide Cohort Study
    Cho, Jaelim
    Scragg, Robert
    Pandol, Stephen J.
    Petrov, Maxim S.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 170 - 178
  • [26] New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population
    Huang, Brian Z.
    Pandol, Stephen J.
    Jeon, Christie Y.
    Chari, Suresh T.
    Sugar, Catherine A.
    Chao, Chun R.
    Zhang, Zuo-Feng
    Wu, Bechien U.
    Setiawan, Veronica Wendy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) : 1812 - +
  • [27] New-onset diabetes mellitus and risk of pancreatic cancer: A systematic review and meta analysis.
    Albawaliz, Anas
    Bataineh, Adam
    El Kurdi, Bara
    Babar, Sumbal
    Abonofal, Abdulrahman
    Alhabhbeh, Ammar
    Alomari, Mohammad
    Qasem, Abdulraheem M. S.
    Sanaka, Madhusudhan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes
    Boursi, Ben
    Finkelman, Brian
    Giantonio, Bruce J.
    Haynes, Kevin
    Rustgi, Anil K.
    Rhim, Andrew D.
    Mamtani, Ronac
    Yang, Yu-Xiao
    GASTROENTEROLOGY, 2017, 152 (04) : 840 - +
  • [29] Comparison of Clinical Profiles of New-Onset Diabetes in Pancreatic Cancer (PaC) and New-Onset Type 2 DM
    Kamada, P.
    Rabe, K.
    Srinivasan, S.
    Chari, S. T.
    PANCREAS, 2009, 38 (08) : 1011 - 1012
  • [30] Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol
    Antolino, Laura
    La Rocca, Mara
    Todde, Federico
    Catarinozzi, Elena
    Aurello, Paolo
    Bollanti, Lucilla
    Ramacciato, Giovanni
    D'Angelo, Francesco
    TUMORI JOURNAL, 2018, 104 (04): : 312 - 314
12345